Study Links Wider Surgical Margins to Lower Sarcoma Recurrence
Researchers found local recurrence in children and young adults with soft tissue sarcoma fell as the margin of healthy tissue removed during surgery grew.
Updated on Nov. 9, 2026 in Cancer
A study published in JAMA Surgery examined 266 children and young adults with nonmetastatic soft tissue sarcoma who underwent R0 resection, finding a 5-year cumulative local recurrence incidence of 4.4%. Recurrence was lower among patients who also received chemotherapy and among those with wider surgical margins.
Why it matters
The findings provide measured data on how margin width and multimodality treatment relate to local tumor control in a rare pediatric and young adult cancer population. Clinicians planning surgery for these tumors can use margin-specific recurrence rates when weighing treatment approaches.
The study reports a 5-year local recurrence incidence of 4.4% across 266 patients, with 5.6% in the surgery-alone group versus 2.3% in the surgery-plus-chemotherapy group. Recurrence fell from 4.9% at 1-mm margins to 2.0% at 2- to 5-mm margins and 0% at 6-mm or larger margins, though the extraction does not address the study's limitations.
The players
Stanford University School of Medicine
A medical school in Palo Alto, California, affiliated with Stanford University, whose researchers authored the study.
The details
Researchers examined how the extent of negative surgical margins affects local tumor control in patients treated with risk-adapted multimodality therapy. Patients with tumors larger than 5 cm were treated with margin-negative surgery followed by chemoradiotherapy, and 1.7% of patients with initially unresectable disease who received neoadjuvant chemoradiotherapy experienced local recurrence.
Timeline
The study measured cumulative local recurrence incidence over a five-year period.
Big Picture
The study sits within the risk-adapted multimodality approach used in pediatric soft tissue sarcoma care, where surgery is combined with chemotherapy and radiation according to tumor features. Its margin-specific recurrence figures add measured detail to how that approach performs in children and young adults with nonmetastatic disease.
For families and clinicians dealing with pediatric soft tissue sarcoma, the margin data suggests that how much healthy tissue is removed at surgery and whether chemotherapy is added both matter for reducing local recurrence. Patients and caregivers can raise margin width and multimodality options with their treatment teams when discussing surgical plans.
The takeaway
Wider surgical margins and the addition of chemotherapy were each associated with lower local recurrence in this cohort, offering measurable guidance for treatment discussions. Patients should review these margin-specific figures with their oncology team when planning care.
Further reading
Explore more on Cancer research and treatment outcomes.
Source note: This article includes information reported by Cancer Therapy Advisor.
